Egyptian Drug Authority · Egypt
DEA-EG-2022-0008
Tier 1 · Regulator-publishedUnclassifiedRecallStatus · active
- Issuing authority
- Egyptian Drug Authority (EDA)
- Authority reference
- Periodic report no.(8) For 2022
- Date issued
- 06 Apr 2022
- Recorded by us
- 2026-09-06 19:45:29 UTC
- Product
- ERYTHROROUS W.S.P
- INN / active substance
- Not stated by the issuing authority
- Dosage form
- Not stated by the issuing authority
- Strength
- Not stated by the issuing authority
- Manufacturer
- Not stated by the issuing authority
- Manufacturer country
- Not stated by the issuing authority
- MAH or importer
- Not stated by the issuing authority
- Batch numbers
- 20703
- Expiry dates
- Not published with the notice
- Action type
- Recall
- Classification
- Not stated by the issuing authority
- Indicative severity
- Not assessed by Drug Eye Africa
- Defect category
- Not stated by the issuing authority
- Product type
- Not stated by the issuing authority
- ATC code
- Not stated by the issuing authority
- Affected markets
- Egypt — no market beyond the issuing country was named on the notice
- Cross-border event
- Not linked to a cross-border event
- Notice text
- @egyptiandrugauthority
www.edaegypt.gov.eg
15301
٦ ابريل ٢٢٠٢
وذلـــك لكون المســـتحضر صادر لـــه عدم مطابقـــة نهائية من حيث
من معامل هيئة الدواء المصرية.WATER CONTENT
وعليـــه يتعين الالتـــزام بما جاء بعاليه وعلى شـــركات التوزيع تجميد
الأرصدة الموجودة لديهم من ذلك المســـتحضر التي ينطبق عليها
المواصفات.
ERYTHROROUS W.S.P
20703رقم التشغيلة
الشركة المصنعة للمستحضر : مارتيروس
ضبط وتحريز العبوات من المستحضر البيطرى التالي:
منشور
غير مطابقOriginal language: ar
- Notice text in English
- Non-conformity circular. The packs of the following veterinary product are to be impounded and seized: ERYTHROROUS W.S.P, batch number 20703, manufactured by Martyros. A final finding of non-conformity on water content has been issued by the laboratories of the Egyptian Drug Authority. The above must be complied with, and distribution companies must freeze the stocks they hold of the affected product. Dated 6 April 2022.Machine translation, produced by Drug Eye Africa and not checked by the issuing authority. The authority stated only the text above it.
- Status
- Active
- Superseded by
- Not superseded. This is the current version.
- Version
- 1
Where this record came from, and what is held to show it.
- Copy of the source
- Taken and held by Drug Eye Africa, so the record survives the link above being moved or withdrawn. Not yet published at an address you can open.Ask us for it and check it against the fingerprint below.
- Fingerprint
- e014c8a8c9b1f393beb49a9269ee462b58fbe5fe1e6cd0ef311368bdc0add815SHA-256 of the copy held. Any file that produces this number is that copy, byte for byte; any file that does not is a different document.
- Copy taken
- 2026-09-06 20:35:38 UTC
Cite this record
Drug Eye Africa (2022). DEA-EG-2022-0008: ERYTHROROUS W.S.P — Recall, Egyptian Drug Authority. Register of African Regulatory Actions. https://drugeyeafrica.org/register/notice/eg/2022/dea-eg-2022-0008Version history
—No version history recorded for this record.
—Corrections appear here and in the site-wide log. Records are superseded, never deleted.
Verification
Tier 1 — Published by the issuing regulator on its own channel and captured by Drug Eye Africa, with the source document archived.
Indexing
This record is indexable: it is dated, names a product, and carries either a batch number or a stated reason.